Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Indivior Share News (INDV)
INDV Share
Price
INDV Share
News
INDV Share
Chat
INDV Share
Trades2,517
INDV
Live RNS
INDV Share
Charts
INDV Broker
Ratings
INDV Directors
Deals
INDV Financial
Diary
INDV
Fundamentals
INDV Short
Positions1
INDV
Media
INDV Company
Research
INDV Company
Timeline1
- There is currently no data for INDV
Indivior News
TRADING UPDATES: C4X Discovery inks Indivior deal, Digitalbox expands
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
LONDON BROKER RATINGS: KBW cuts Aviva 'market perform'
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:
Indivior raises 2023 guidance after strong half-year progress
(Alliance News) - Indivior PLC on Thursday celebrated a strong recent six months and second quarter that brough increased profit and revenue, boosting...
Indivior lifts guidance after strong first half
(Sharecast News) - Pharmaceuticals firm Indivior reported a 24% improvement in net revenue in its half-year report on Thursday, to $529m.
LONDON BRIEFING: Shares on the rise; Frasers buys into AO World
(Alliance News) - Stocks in London were set to open higher on Monday, at the start of a busy week of central bank moves.
Indivior reaches settlement in litigation with US states
(Sharecast News) - Addiction treatment-focussed pharmaceuticals company Indivior announced on Monday that its subsidiary Indivior Inc has successfully...
Indivior settles antitrust claims in US regarding Suboxone drug
(Alliance News) - Indivior PLC on Friday said it has reached an agreement to resolve the claims brought in antitrust multi-district litigation regardi...
LONDON BROKER RATINGS: Numis starts Tristel with 'add'
(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:
Follow the stocks
